Phase II study of navelbine in advanced renal cell carcinoma

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

NPJ breast cancer·2025

Real-time investigation of an influenza A(H3N2) virus outbreak in a refugee community, November 2022.

Public health·2024

Quantifying hospital environmental ventilation using carbon dioxide monitoring - a multicentre study.

Anaesthesia·2023

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

British journal of cancer·2023

Evidence for X(3872) in Pb-Pb Collisions and Studies of its Prompt Production at sqrt[s_{NN}]=5.02 TeV.

Physical review letters·2022

Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns.

European journal of cancer (Oxford, England : 1990)·2026

Thirty years of adjuvant therapy: From treating risk to treating residual disease.

European journal of cancer (Oxford, England : 1990)·2026

Artificial intelligence for brain cancer management: multimodal digital workflows for diagnosis, treatment planning, and longitudinal monitoring.

European journal of cancer (Oxford, England : 1990)·2026

Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.

European journal of cancer (Oxford, England : 1990)·2026

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.

European journal of cancer (Oxford, England : 1990)·2026

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

European journal of cancer (Oxford, England : 1990)·2026

Cartap hydrochloride induces dose-dependent oxidative stress and HSP70 overexpression in testicular tissue of Wistar rats: protective effect of α-tocopherol.

Reproductive toxicology (Elmsford, N.Y.)·2026

Targeting oxaliplatin-induced peripheral neuropathy: neurobiological mechanisms, therapeutic evidence, and translational perspectives.

Neuroscience·2026

Effects of non-pharmacological interventions on chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis.

International journal of nursing studies·2026

Disulfiram reverses fluconazole-resistance mediated by Cdr1 in Candida albicans and interferes with biofilm formation.

Applied microbiology and biotechnology·2026

Evaluation of Phytocannabinoids as Antitumor Agents against Ovarian Cancer Cells in Combination with Carboplatin.

ACS omega·2026

An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy.

Mutation research. Genetic toxicology and environmental mutagenesis·2026

Related Experiment Videos

Phase II study of navelbine in advanced renal cell carcinoma

Related Concept Videos

The role of the molecular tumor board: learnings from the ROME trial.

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

Real-time investigation of an influenza A(H3N2) virus outbreak in a refugee community, November 2022.

Quantifying hospital environmental ventilation using carbon dioxide monitoring - a multicentre study.

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

Evidence for X(3872) in Pb-Pb Collisions and Studies of its Prompt Production at sqrt[s_{NN}]=5.02 TeV.

Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns.

Thirty years of adjuvant therapy: From treating risk to treating residual disease.

Artificial intelligence for brain cancer management: multimodal digital workflows for diagnosis, treatment planning, and longitudinal monitoring.

Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

Cartap hydrochloride induces dose-dependent oxidative stress and HSP70 overexpression in testicular tissue of Wistar rats: protective effect of α-tocopherol.

Targeting oxaliplatin-induced peripheral neuropathy: neurobiological mechanisms, therapeutic evidence, and translational perspectives.

Effects of non-pharmacological interventions on chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis.

Disulfiram reverses fluconazole-resistance mediated by Cdr1 in Candida albicans and interferes with biofilm formation.

Evaluation of Phytocannabinoids as Antitumor Agents against Ovarian Cancer Cells in Combination with Carboplatin.

An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy.

Related Experiment Videos

Phase II study of navelbine in advanced renal cell carcinoma

Related Concept Videos

Related Articles